Mr. Graham Farrell reports

CIPHER PHARMACEUTICALS SCHEDULES Q1 2024 EARNINGS RELEASE AND CONFERENCE CALL

Cipher Pharmaceuticals Inc. will release its financial results for the first quarter of 2024 after the market close on Thursday, May 9, 2024. The company will also hold a conference call on Friday, May 10, 2024, at 8:30 a.m. ET to discuss the results and corporate developments.

Conference call details

Date: May 10, 2024

Time: 8:30 a.m. ET

Dial-in number: 416-764-8650 or 888-664-6383

Replay: 416-764-8677 or 888-390-0541

Code: 196164 followed by pound key

Expires: May 17, 2024

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early- to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the United States and South America.